Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: Adipocyte-derived stem cell-based gene therapy upon adipogenic differentiation on microcarriers attenuates type 1 diabetes in mice

Fig. 5

Comparison of the in vivo viability of ADSC-derived cells in the presence or absence of the cytopore 1 microcarrier. ADSCs or adipogenic-differentiated ADSCs (ADs) were labeled with DiR. Cells seeded on cytopore 1 microcarrier (MC) or not were subcutaneously injected into the inguinal fat pad of the nude mice (n = 3 for each group). a Cell viability calculated according to the fluorescent intensity at indicated time points. Data were presented as mean ± SD. *p < 0.05, AD+MC vs AD; #p < 0.05; ##p < 0.01, ADSC+MC vs ADSC, was considered significant. Representative live image pictures of AD (b, c) and AD+MC (d, e) at day 0 (b, d) and 14 (c, e)

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512